Lab test
PreclinicalBiologic
Lab test is one of 22 biologic programs targeting Atrial Fibrillation. It is currently in Preclinical.
1
Indications
1
Total Trials
1
Active Trials
21
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
376 competitors in Atrial Fibrillation
#DrugCompanyPhaseTrials
1Anticoagulants
SanofiPreclinical
Direct Anticoagulant
BayerPreclinical
SGLT2 Inhibitor
Eli LillyPreclinical
Statin
Bristol-Myers SquibbPreclinical
Warfarin Sodium
Boehringer IngelheimPreclinical
Magnesium SO4
HHospital de Base
Preclinical
Medication
NNYU Langone Health
Preclinical
Bupivacain
IIstanbul University
Preclinical
Blood Taken
HHospices Civils de Lyon
Preclinical
Anticoagulation
HHospital Álvaro Cunqueiro
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Lab test. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Biologic[2]
- Highest Phase
- Preclinical[1]
- Company
- UUniversity Hospital, Bordeaux